Last reviewed · How we verify

NCT05884216

Entarik Feeding Tube System Placement in Adult ICU

Terminated NA Last updated 20 November 2025
What this trial tests

NA trial testing Entarik Feeding Tube System in Nasogastric Tube in 45 participants. Terminated before completion.

Timeline
30 May 2023
Primary endpoint
15 January 2025
23 January 2025

Quick facts

Lead sponsorGravitas Medical, Inc.
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment45
Start date30 May 2023
Primary completion15 January 2025
Estimated completion23 January 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Gravitas Medical, Inc.

Who can join

18 and older, any sex, with Nasogastric Tube. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the safety and effectiveness of the Entarik Feeding Tube System in an adult ICU patient population for the administration of nutrition, fluids and medications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nasogastric Tube

Currently open trials in the same condition.

Other Gravitas Medical, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05884216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing